Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 118 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact118 DOIs

Add abstracts to 19 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact19 DOIs

Deposit reference lists for 13 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact13 DOIs

DOIs for this ISSN

Showing the top 5 of 314 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Clinicopathological Features and Treatment of Ectopic Varice… (10.4061/2011/960720)	Abstract ORCID	94.60	77
2	Esophageal Varices: Pathophysiology, Approach, and Clinical… (10.1155/2012/795063)	Abstract References ORCID	92.28	16
3	Indications and Contraindications for Liver Transplantation (10.4061/2011/121862)	Abstract ORCID	87.41	55
4	Experience Since MELD Implementation: How Does the New Syste… (10.1155/2012/264015)	Abstract ORCID	75.26	31
5	Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Cl… (10.4061/2011/489342)	Abstract ORCID	75.26	31
6	Multiple Factors Involved in Nonalcoholic Hepatitis Pathogen… (10.1155/2012/429805)	Abstract References ORCID	71.57	8
7	A Primer on Detecting Cirrhosis and Caring for These Patient… (10.4061/2011/801983)	Abstract ORCID	66.11	20
8	Targeted Therapy in Hepatocellular Carcinoma (10.4061/2011/348297)	Abstract ORCID	65.05	19
9	Management of Cardiopulmonary Complications of Cirrhosis (10.4061/2011/280569)	Abstract ORCID	63.94	18
10	The Molecular Pathogenesis and Clinical Implications of Hepa… (10.4061/2011/818672)	Abstract ORCID	62.76	17
11	Regulation of the Hepatocyte Cell Cycle: Signaling Pathways… (10.1155/2012/592354)	Abstract References ORCID	58.36	5
12	MicroRNA Signature in Alcoholic Liver Disease (10.1155/2012/498232)	ORCID	50.94	108
13	Prescribing Medications in Patients with Decompensated Liver… (10.4061/2011/519526)	Abstract ORCID	50.00	9
14	Management of Coagulopathy in Patients with Decompensated Li… (10.4061/2011/695470)	Abstract ORCID	50.00	9
15	Liver Injury Induced by Anticancer Chemotherapy and Radiatio… (10.1155/2013/815105)	ORCID	49.56	95
16	Changing Epidemiology of Hepatocellular Adenoma in the Unite… (10.1155/2013/604860)	ORCID	49.09	91
17	Mechanisms and Biomarkers of Apoptosis in Liver Disease and… (10.1155/2012/648915)	ORCID	48.36	85
18	Functional Relationships between Lipid Metabolism and Liver… (10.1155/2012/549241)	ORCID	47.98	82
19	Biomarkers for Hepatocellular Carcinoma (10.1155/2012/859076)	ORCID	47.58	79
20	Betaine Treatment Attenuates Chronic Ethanol-Induced Hepatic… (10.1155/2012/962183)	ORCID	46.58	72
21	The Effect of Artichoke Leaf Extract on Alanine Aminotransfe… (10.1155/2016/4030476)	ORCID	46.13	69
22	Cholangiopathy: Genetics, Mechanism, and Pathology (10.1155/2012/950713)	Abstract References ORCID	45.15	3
23	Screening for Hepatocellular Carcinoma (10.4061/2011/363151)	Abstract ORCID	45.15	7
24	Benign Hepatocellular Tumors in Children: Focal Nodular Hype… (10.1155/2013/215064)	ORCID	44.63	60
25	Neuroendocrine Liver Metastases and Orthotopic Liver Transpl… (10.4061/2011/742890)	Abstract	44.45	59
26	Hepatocytes Polyploidization and Cell Cycle Control in Liver… (10.1155/2012/282430)	ORCID	44.27	58
27	CYP2E1 Sensitizes the Liver to LPS- and TNF<i>α</i>-Induced… (10.1155/2012/582790)	ORCID	43.70	55
28	Treatment of Liver Metastases in Patients with Neuroendocrin… (10.4061/2011/154541)	Abstract	43.70	55
29	Cell Signals Influencing Hepatic Fibrosis (10.1155/2012/158547)	ORCID	43.51	54
30	Clinical Manifestations of Portal Hypertension (10.1155/2012/203794)	ORCID	42.69	50
31	Milan Criteria and UCSF Criteria: A Preliminary Comparative… (10.1155/2012/253517)	ORCID	42.69	50
32	A Current Review of the Diagnostic and Treatment Strategies… (10.1155/2012/480309)	ORCID	42.47	49
33	Nutrition and Nonalcoholic Fatty Liver Disease: The Signific… (10.1155/2012/925807)	ORCID	42.47	49
34	Hepatic Angiomyolipoma: Diagnostic Findings and Management (10.1155/2012/410781)	ORCID	41.80	46
35	The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepato… (10.1155/2012/328372)	ORCID	41.57	45
36	Alcohol Activates TGF-Beta but Inhibits BMP Receptor-Mediate… (10.1155/2012/459278)	ORCID	41.33	44
37	Factors That Could Impact on Liver Fibrosis Staging by Trans… (10.1155/2015/624596)	ORCID	41.09	43
38	Regulation of Signal Transduction by Glutathione Transferase… (10.1155/2012/137676)	ORCID	40.84	42
39	The Value of Serum Midkine Level in Diagnosis of Hepatocellu… (10.1155/2015/146389)	ORCID	40.84	42
40	Analysis and Algorithmic Generation of Hepatic Vascular Syst… (10.1155/2012/357687)	ORCID	40.58	41
41	Pathophysiology of Portal Hypertension and Esophageal Varice… (10.1155/2012/895787)	ORCID	39.78	38
42	Role of Adaptive Immunity in Alcoholic Liver Disease (10.1155/2012/893026)	ORCID	39.49	37
43	Acalculous Acute Cholecystitis in Previously Healthy Childre… (10.1155/2015/459608)	ORCID	39.21	36
44	Mystery of Hepatitis E Virus: Recent Advances in Its Diagnos… (10.1155/2015/872431)	ORCID	38.60	34
45	Circulating Tumor Cells Measurements in Hepatocellular Carci… (10.1155/2012/684802)	ORCID	38.29	33
46	Therapeutic Potential of HGF-Expressing Human Umbilical Cord… (10.1155/2016/5452487)	ORCID	38.29	33
47	Management of Anticoagulation for Portal Vein Thrombosis in… (10.1155/2012/672986)	ORCID	37.96	32
48	Treatment of Neuroendocrine Tumor Liver Metastases (10.1155/2012/973946)	ORCID	37.96	32
49	Overview of Hepatocellular Adenoma in Japan (10.1155/2012/648131)	ORCID	37.28	30
50	Alpha-Fetoprotein and Novel Tumor Biomarkers as Predictors o… (10.1155/2012/893103)	ORCID	37.28	30